ABBOTT LABORATORIES — Director's Dealing 2017

Feb 24, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-02-23

Reporting Person: Funck Robert E (Vice President, Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-23	Common shares without par value	M	25500	$26.6973	Acquired	117579	Direct
2017-02-23	Common shares without par value	S	25500	$45.50	Disposed	92079	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-23	Option (right to buy)	$26.6973	M	25500	Disposed	2018-02-14	Common shares (25500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Profit Sharing Trust	16654	Indirect
Common shares without par value	500	Indirect
Common shares without par value	500	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 23, 2017.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.